FindTrial
Sign In

Hyperthyroidism in Patients with Molar Pregnancy

Hyperthyroidism in Patient with Molar Pregnancy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20180129007
Enrollment
Unknown
Registered
2018-01-29
Start date
2015-04-10
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None Molar pregnancy&#44

Interventions

Inclusion criteria &#45
Age ≥ 15 years old &#45
Inpatients of Siriraj Hospital between January 2004 – December 2013 &#45
Diagnosis of molar pregnancy with documented ICD&#45
10 O010 (Classical Hydatidiform Mole) or O019 (Hydatidiform Mole&#44
unspecified) or O011 (Incomplete and Partial Hydatidiform Mole) &#45
Thyroid function test was measured
TSH and T4/FT4 and T3/FT3 Exclusion criteria &#45
Incomplete inpatient medical record &#45
Overt abnormal thyroid status before pregnancy Receiving medications that alter thyroid status e.g. Lithium&#44
Thyroxine&#44
Amiodarone before pregnancy
Diagnostic
Molar pregnancy patients

Sponsors

None
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria - Age ≥ 15 years old - Inpatients of Siriraj Hospital between January 2004 – December 2013 - Diagnosis of molar pregnancy with documented ICD-10 O010 (Classical Hydatidiform Mole) or O019 (Hydatidiform Mole, unspecified) or O011 (Incomplete and Partial Hydatidiform Mole) - Thyroid function test was measured; TSH and T4/FT4 and T3/FT3

Exclusion criteria

Exclusion criteria: Exclusion criteria - Incomplete inpatient medical record - Overt abnormal thyroid status before pregnancy Receiving medications that alter thyroid status e.g. Lithium, Thyroxine, Amiodarone before pregnancy

Design outcomes

Primary

MeasureTime frame
To study relationship between thyroid hormone in patients with molar pregnancy and beta-hCG level during molar pregnancy (Before and after treatment) Measure Beta-hCG and FT3, FT4 and TSH—

Secondary

MeasureTime frame
N/A N/A N/A—

Countries

Thailand

Contacts

Public ContactTada Kunavisarut

Mahidol University

kunavisarut@gmail.com024197799

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026